0001209191-20-017232.txt : 20200309 0001209191-20-017232.hdr.sgml : 20200309 20200309161015 ACCESSION NUMBER: 0001209191-20-017232 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200305 FILED AS OF DATE: 20200309 DATE AS OF CHANGE: 20200309 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Driscoll Martin J CENTRAL INDEX KEY: 0001339402 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37718 FILM NUMBER: 20698063 MAIL ADDRESS: STREET 1: C/O JAVELIN PHARMACEUTICALS, INC. STREET 2: 125 CAMBRIDGE PARK DRIVE CITY: CAMBRIDGE STATE: MA ZIP: 02140 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Spring Bank Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001566373 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 522386345 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 35 PARKWOOD DRIVE STREET 2: SUITE 210 CITY: HOPKINTON STATE: MA ZIP: 01748 BUSINESS PHONE: 508-473-5993 X119 MAIL ADDRESS: STREET 1: 35 PARKWOOD DRIVE STREET 2: SUITE 210 CITY: HOPKINTON STATE: MA ZIP: 01748 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-03-05 0 0001566373 Spring Bank Pharmaceuticals, Inc. SBPH 0001339402 Driscoll Martin J C/O SPRING BANK PHARMACEUTICALS, INC. 35 PARKWOOD DRIVE, SUITE 210 HOPKINTON MA 01748 1 1 0 0 President and CEO Stock Option (Right to Buy) 1.41 2020-03-05 4 A 0 40000 0.00 A 2030-03-04 Common Stock 40000 40000 D Restricted Stock Units 2020-03-05 4 A 0 40000 0.00 A Common Stock 40000 40000 D This option was granted on March 5, 2020, with 25% of the shares subject to the option vesting on March 5, 2021 and the remaining 75% of the shares subject to the option vesting in 36 equal monthly installments thereafter. Each restricted stock unit represents a contingent right to receive one share of Spring Bank Pharmaceuticals, Inc. common stock. The restricted stock units will vest in two installments. Fifty percent will vest on March 5, 2021 and the remaining fifty percent will vest on December 31, 2021. /s/ Lori Firmani, Attorney-in-Fact 2020-03-09